SCHEMBL3704252

SCHEMBL3704252

Oc1nc2nccn2c(O)c1-c1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.41
CCNE2 O96020 2/20 0.40
CCNE1 P24864 2/20 0.40
CDK2 P24941 2/20 0.40
MAP2K1 Q02750 1/20 0.39
KDM4E B2RXH2 2/20 0.38
GRIA1 P42261 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA3 P34903 1/20 0.35
NPC1 O15118 2/20 0.33
GAA P10253 2/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
USP7 Q93009 1/20 0.32
KLK7 P49862 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5252895 0.85 CCNE2 (0.35) ADORA2ACCNE2CCNE1CDK2MAP2K1
SCHEMBL5252606 0.80 PDE2A (0.34) CCNE2CCNE1CDK2MAP2K1KDM4E
SCHEMBL3702960 0.77 GRIA1 (0.38) ADORA2ACDK2GRIA1NPC1KLK7
SCHEMBL5593135 0.76 EGLN2 (0.40) CCNE1CDK2MAP2K1NPC1
SCHEMBL14270922 0.74 EGLN2 (0.44) KDM4EGABRG2GABRB3GABRA3NPC1
SCHEMBL3707772 0.74 KDM4E (0.43) ADORA2ACCNE2CCNE1CDK2MAP2K1
SCHEMBL5252323 0.69 PDE2A (0.38) KDM4EGAAMAPK1
SCHEMBL15685795 0.69 MAP2K1 (0.38) MAP2K1KDM4EGAAMAPTMAPK1
SCHEMBL9870867 0.69 GABRA1 (0.42) ADORA2ACCNE2CCNE1CDK2MAP2K1
SCHEMBL2978903 0.68 MAPT (0.42) ADORA2AMAP2K1KDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396330-A1 FUSED PYRIMIDINES Bayer Pharma Aktiengesellschaft (DE) 2011-12-21 EP disclosed
WO-2010091808-A1 FUSED PYRIMIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-19 WO disclosed